Does a urine albumin-to-creatinine ratio of 0.7 mg/mmol indicate low risk for chronic kidney disease progression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A UACR of 0.7 mg/mmol (approximately 6.2 mg/g) indicates LOW risk for chronic kidney disease progression.

This value falls well below the threshold of 30 mg/g (3.4 mg/mmol) that defines albuminuria and is considered normal, placing the patient in the lowest risk category for CKD progression 1, 2.

Understanding the Risk Stratification

The albumin-to-creatinine ratio you've provided needs unit conversion for proper interpretation:

  • 0.7 mg/mmol = approximately 6.2 mg/g (multiply by 8.84 for conversion)
  • Normal UACR is defined as <30 mg/g (<3.4 mg/mmol) 3
  • Your patient's value is 5 times lower than the threshold for abnormal albuminuria

Current Guideline Classification

According to KDIGO 2024 guidelines 4, albuminuria categories are:

  • A1 (normal to mildly increased): <30 mg/g - your patient is here
  • A2 (moderately increased): 30-300 mg/g
  • A3 (severely increased): >300 mg/g

The risk of CKD progression increases continuously with higher UACR values, and your patient sits at the very bottom of this continuum 5.

Important Nuances from Recent Research

While guidelines define <30 mg/g as normal, emerging research suggests even within the "normal" range, there's a gradient of risk:

  • A 2022 study found that UACR values >10 mg/g in diabetic patients were associated with increased CKD progression risk 6
  • Another study identified >10.2 mg/g as a threshold in patients with metabolic syndrome 7
  • However, at 6.2 mg/g, your patient remains below even these lower research-derived thresholds

Clinical Implications

Your patient with UACR of 0.7 mg/mmol (6.2 mg/g) requires:

  1. Annual monitoring of both UACR and eGFR 1, 2 - this is standard surveillance, not because of high risk
  2. No specific albuminuria-targeted therapy - ACE inhibitors or ARBs are NOT recommended for primary prevention when UACR is <30 mg/g and blood pressure is normal 1, 8
  3. Focus on standard risk factor management:
    • Optimize glucose control (if diabetic) 1
    • Maintain blood pressure <140/90 mmHg (or <130/80 if albuminuria were present) 5
    • Address cardiovascular risk factors

Critical Caveat

This single measurement should be confirmed if clinical decisions depend on it 3. The guidelines recommend confirming abnormal values (>30 mg/g) with 2 of 3 samples, but at this low level, a single measurement is generally sufficient for reassurance. However, ensure:

  • Patient avoided vigorous exercise 24 hours before collection 3
  • No concurrent urinary tract infection
  • First morning sample is preferred for accuracy 3

Bottom line: At 0.7 mg/mmol (6.2 mg/g), this patient has normal albuminuria and low risk for CKD progression. Continue annual surveillance and standard preventive care, but no albuminuria-specific interventions are warranted 1, 4, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.